Intermittent Claudication Market - Global Outlook and Forecast 2021-2027
This report contains market size and forecasts of Intermittent Claudication in Global, including the following market information:
Global Intermittent Claudication Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Intermittent Claudication market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intermittent Claudication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intermittent Claudication Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Intermittent Claudication Market Segment Percentages, By Type, 2020 (%)
China Intermittent Claudication Market Segment Percentages, By Application, 2020 (%)
Global Intermittent Claudication Market Segment Percentages, By Region and Country, 2020 (%)
The report also provides analysis of leading market participants including:
Total Intermittent Claudication Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Intermittent Claudication Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Global Intermittent Claudication Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Intermittent Claudication market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intermittent Claudication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intermittent Claudication Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Intermittent Claudication Market Segment Percentages, By Type, 2020 (%)
- by Treatment Process
- Medication Therapies
- Revascularization
- by Drug Type
- ALD-301
- DVC1-0101
- K-134
- LT-0101
- PLX-PAD
- Tirasemtiv
China Intermittent Claudication Market Segment Percentages, By Application, 2020 (%)
- Hospitals
- Clinics
- Home Healthcare
- Others
Global Intermittent Claudication Market Segment Percentages, By Region and Country, 2020 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Total Intermittent Claudication Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Intermittent Claudication Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
- I'ROM GROUP(DNAVEC Corporation)
- Nuo Therapeutics Inc.
- Kowa Company Ltd.
- LTT Bio-Pharma
- Pluristem Therapeutics Inc.
- Nuo Therapeutics, Inc.(Aldagen, Inc.)
- Genovate Biotechnology Co., Ltd.
- Novartis AG
- ID Pharma Co., Ltd
- Helixmith Co., Ltd.
- G. Pohl-Boskamp GmbH & Co. KG
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Intermittent Claudication Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Intermittent Claudication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INTERMITTENT CLAUDICATION OVERALL MARKET SIZE
2.1 Global Intermittent Claudication Market Size: 2021 VS 2027
2.2 Global Intermittent Claudication Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Intermittent Claudication Players in Global Market
3.2 Top Global Intermittent Claudication Companies Ranked by Revenue
3.3 Global Intermittent Claudication Revenue by Companies
3.4 Top 3 and Top 5 Intermittent Claudication Companies in Global Market, by Revenue in 2020
3.5 Global Companies Intermittent Claudication Product Type
3.6 Tier 1, Tier 2 and Tier 3 Intermittent Claudication Players in Global Market
3.6.1 List of Global Tier 1 Intermittent Claudication Companies
3.6.2 List of Global Tier 2 and Tier 3 Intermittent Claudication Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Intermittent Claudication Market Size Markets, 2021 & 2027
4.1.2 Medication Therapies
4.1.3 Revascularization
4.2 By Type - Global Intermittent Claudication Revenue & Forecasts
4.2.1 By Type - Global Intermittent Claudication Revenue, 2016-2021
4.2.2 By Type - Global Intermittent Claudication Revenue, 2022-2027
4.2.3 By Type - Global Intermittent Claudication Revenue Market Share, 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Intermittent Claudication Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Home Healthcare
5.1.5 Others
5.2 By Application - Global Intermittent Claudication Revenue & Forecasts
5.2.1 By Application - Global Intermittent Claudication Revenue, 2016-2021
5.2.2 By Application - Global Intermittent Claudication Revenue, 2022-2027
5.2.3 By Application - Global Intermittent Claudication Revenue Market Share, 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Intermittent Claudication Market Size, 2021 & 2027
6.2 By Region - Global Intermittent Claudication Revenue & Forecasts
6.2.1 By Region - Global Intermittent Claudication Revenue, 2016-2021
6.2.2 By Region - Global Intermittent Claudication Revenue, 2022-2027
6.2.3 By Region - Global Intermittent Claudication Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Intermittent Claudication Revenue, 2016-2027
6.3.2 US Intermittent Claudication Market Size, 2016-2027
6.3.3 Canada Intermittent Claudication Market Size, 2016-2027
6.3.4 Mexico Intermittent Claudication Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Intermittent Claudication Revenue, 2016-2027
6.4.2 Germany Intermittent Claudication Market Size, 2016-2027
6.4.3 France Intermittent Claudication Market Size, 2016-2027
6.4.4 U.K. Intermittent Claudication Market Size, 2016-2027
6.4.5 Italy Intermittent Claudication Market Size, 2016-2027
6.4.6 Russia Intermittent Claudication Market Size, 2016-2027
6.4.7 Nordic Countries Intermittent Claudication Market Size, 2016-2027
6.4.8 Benelux Intermittent Claudication Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Intermittent Claudication Revenue, 2016-2027
6.5.2 China Intermittent Claudication Market Size, 2016-2027
6.5.3 Japan Intermittent Claudication Market Size, 2016-2027
6.5.4 South Korea Intermittent Claudication Market Size, 2016-2027
6.5.5 Southeast Asia Intermittent Claudication Market Size, 2016-2027
6.5.6 India Intermittent Claudication Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Intermittent Claudication Revenue, 2016-2027
6.6.2 Brazil Intermittent Claudication Market Size, 2016-2027
6.6.3 Argentina Intermittent Claudication Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Intermittent Claudication Revenue, 2016-2027
6.7.2 Turkey Intermittent Claudication Market Size, 2016-2027
6.7.3 Israel Intermittent Claudication Market Size, 2016-2027
6.7.4 Saudi Arabia Intermittent Claudication Market Size, 2016-2027
6.7.5 UAE Intermittent Claudication Market Size, 2016-2027
7 PLAYERS PROFILES
7.1 I'ROM GROUP(DNAVEC Corporation)
7.1.1 I'ROM GROUP(DNAVEC Corporation) Corporate Summary
7.1.2 I'ROM GROUP(DNAVEC Corporation) Business Overview
7.1.3 I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Major Product Offerings
7.1.4 I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Revenue in Global (2016-2021)
7.1.5 I'ROM GROUP(DNAVEC Corporation) Key News
7.2 Nuo Therapeutics Inc.
7.2.1 Nuo Therapeutics Inc. Corporate Summary
7.2.2 Nuo Therapeutics Inc. Business Overview
7.2.3 Nuo Therapeutics Inc. Intermittent Claudication Major Product Offerings
7.2.4 Nuo Therapeutics Inc. Intermittent Claudication Revenue in Global (2016-2021)
7.2.5 Nuo Therapeutics Inc. Key News
7.3 Kowa Company Ltd.
7.3.1 Kowa Company Ltd. Corporate Summary
7.3.2 Kowa Company Ltd. Business Overview
7.3.3 Kowa Company Ltd. Intermittent Claudication Major Product Offerings
7.3.4 Kowa Company Ltd. Intermittent Claudication Revenue in Global (2016-2021)
7.3.5 Kowa Company Ltd. Key News
7.4 LTT Bio-Pharma
7.4.1 LTT Bio-Pharma Corporate Summary
7.4.2 LTT Bio-Pharma Business Overview
7.4.3 LTT Bio-Pharma Intermittent Claudication Major Product Offerings
7.4.4 LTT Bio-Pharma Intermittent Claudication Revenue in Global (2016-2021)
7.4.5 LTT Bio-Pharma Key News
7.5 Pluristem Therapeutics Inc.
7.5.1 Pluristem Therapeutics Inc. Corporate Summary
7.5.2 Pluristem Therapeutics Inc. Business Overview
7.5.3 Pluristem Therapeutics Inc. Intermittent Claudication Major Product Offerings
7.5.4 Pluristem Therapeutics Inc. Intermittent Claudication Revenue in Global (2016-2021)
7.5.5 Pluristem Therapeutics Inc. Key News
7.6 Nuo Therapeutics, Inc.(Aldagen, Inc.)
7.6.1 Nuo Therapeutics, Inc.(Aldagen, Inc.) Corporate Summary
7.6.2 Nuo Therapeutics, Inc.(Aldagen, Inc.) Business Overview
7.6.3 Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Major Product Offerings
7.6.4 Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Revenue in Global (2016-2021)
7.6.5 Nuo Therapeutics, Inc.(Aldagen, Inc.) Key News
7.7 Genovate Biotechnology Co., Ltd.
7.7.1 Genovate Biotechnology Co., Ltd. Corporate Summary
7.7.2 Genovate Biotechnology Co., Ltd. Business Overview
7.7.3 Genovate Biotechnology Co., Ltd. Intermittent Claudication Major Product Offerings
7.4.4 Genovate Biotechnology Co., Ltd. Intermittent Claudication Revenue in Global (2016-2021)
7.7.5 Genovate Biotechnology Co., Ltd. Key News
7.8 Novartis AG
7.8.1 Novartis AG Corporate Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Intermittent Claudication Major Product Offerings
7.8.4 Novartis AG Intermittent Claudication Revenue in Global (2016-2021)
7.8.5 Novartis AG Key News
7.9 ID Pharma Co., Ltd
7.9.1 ID Pharma Co., Ltd Corporate Summary
7.9.2 ID Pharma Co., Ltd Business Overview
7.9.3 ID Pharma Co., Ltd Intermittent Claudication Major Product Offerings
7.9.4 ID Pharma Co., Ltd Intermittent Claudication Revenue in Global (2016-2021)
7.9.5 ID Pharma Co., Ltd Key News
7.10 Helixmith Co., Ltd.
7.10.1 Helixmith Co., Ltd. Corporate Summary
7.10.2 Helixmith Co., Ltd. Business Overview
7.10.3 Helixmith Co., Ltd. Intermittent Claudication Major Product Offerings
7.10.4 Helixmith Co., Ltd. Intermittent Claudication Revenue in Global (2016-2021)
7.10.5 Helixmith Co., Ltd. Key News
7.11 G. Pohl-Boskamp GmbH & Co. KG
7.11.1 G. Pohl-Boskamp GmbH & Co. KG Corporate Summary
7.11.2 G. Pohl-Boskamp GmbH & Co. KG Business Overview
7.11.3 G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Major Product Offerings
7.11.4 G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Revenue in Global (2016-2021)
7.11.5 G. Pohl-Boskamp GmbH & Co. KG Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Intermittent Claudication Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Intermittent Claudication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INTERMITTENT CLAUDICATION OVERALL MARKET SIZE
2.1 Global Intermittent Claudication Market Size: 2021 VS 2027
2.2 Global Intermittent Claudication Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Intermittent Claudication Players in Global Market
3.2 Top Global Intermittent Claudication Companies Ranked by Revenue
3.3 Global Intermittent Claudication Revenue by Companies
3.4 Top 3 and Top 5 Intermittent Claudication Companies in Global Market, by Revenue in 2020
3.5 Global Companies Intermittent Claudication Product Type
3.6 Tier 1, Tier 2 and Tier 3 Intermittent Claudication Players in Global Market
3.6.1 List of Global Tier 1 Intermittent Claudication Companies
3.6.2 List of Global Tier 2 and Tier 3 Intermittent Claudication Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Intermittent Claudication Market Size Markets, 2021 & 2027
4.1.2 Medication Therapies
4.1.3 Revascularization
4.2 By Type - Global Intermittent Claudication Revenue & Forecasts
4.2.1 By Type - Global Intermittent Claudication Revenue, 2016-2021
4.2.2 By Type - Global Intermittent Claudication Revenue, 2022-2027
4.2.3 By Type - Global Intermittent Claudication Revenue Market Share, 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Intermittent Claudication Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Home Healthcare
5.1.5 Others
5.2 By Application - Global Intermittent Claudication Revenue & Forecasts
5.2.1 By Application - Global Intermittent Claudication Revenue, 2016-2021
5.2.2 By Application - Global Intermittent Claudication Revenue, 2022-2027
5.2.3 By Application - Global Intermittent Claudication Revenue Market Share, 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Intermittent Claudication Market Size, 2021 & 2027
6.2 By Region - Global Intermittent Claudication Revenue & Forecasts
6.2.1 By Region - Global Intermittent Claudication Revenue, 2016-2021
6.2.2 By Region - Global Intermittent Claudication Revenue, 2022-2027
6.2.3 By Region - Global Intermittent Claudication Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Intermittent Claudication Revenue, 2016-2027
6.3.2 US Intermittent Claudication Market Size, 2016-2027
6.3.3 Canada Intermittent Claudication Market Size, 2016-2027
6.3.4 Mexico Intermittent Claudication Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Intermittent Claudication Revenue, 2016-2027
6.4.2 Germany Intermittent Claudication Market Size, 2016-2027
6.4.3 France Intermittent Claudication Market Size, 2016-2027
6.4.4 U.K. Intermittent Claudication Market Size, 2016-2027
6.4.5 Italy Intermittent Claudication Market Size, 2016-2027
6.4.6 Russia Intermittent Claudication Market Size, 2016-2027
6.4.7 Nordic Countries Intermittent Claudication Market Size, 2016-2027
6.4.8 Benelux Intermittent Claudication Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Intermittent Claudication Revenue, 2016-2027
6.5.2 China Intermittent Claudication Market Size, 2016-2027
6.5.3 Japan Intermittent Claudication Market Size, 2016-2027
6.5.4 South Korea Intermittent Claudication Market Size, 2016-2027
6.5.5 Southeast Asia Intermittent Claudication Market Size, 2016-2027
6.5.6 India Intermittent Claudication Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Intermittent Claudication Revenue, 2016-2027
6.6.2 Brazil Intermittent Claudication Market Size, 2016-2027
6.6.3 Argentina Intermittent Claudication Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Intermittent Claudication Revenue, 2016-2027
6.7.2 Turkey Intermittent Claudication Market Size, 2016-2027
6.7.3 Israel Intermittent Claudication Market Size, 2016-2027
6.7.4 Saudi Arabia Intermittent Claudication Market Size, 2016-2027
6.7.5 UAE Intermittent Claudication Market Size, 2016-2027
7 PLAYERS PROFILES
7.1 I'ROM GROUP(DNAVEC Corporation)
7.1.1 I'ROM GROUP(DNAVEC Corporation) Corporate Summary
7.1.2 I'ROM GROUP(DNAVEC Corporation) Business Overview
7.1.3 I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Major Product Offerings
7.1.4 I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Revenue in Global (2016-2021)
7.1.5 I'ROM GROUP(DNAVEC Corporation) Key News
7.2 Nuo Therapeutics Inc.
7.2.1 Nuo Therapeutics Inc. Corporate Summary
7.2.2 Nuo Therapeutics Inc. Business Overview
7.2.3 Nuo Therapeutics Inc. Intermittent Claudication Major Product Offerings
7.2.4 Nuo Therapeutics Inc. Intermittent Claudication Revenue in Global (2016-2021)
7.2.5 Nuo Therapeutics Inc. Key News
7.3 Kowa Company Ltd.
7.3.1 Kowa Company Ltd. Corporate Summary
7.3.2 Kowa Company Ltd. Business Overview
7.3.3 Kowa Company Ltd. Intermittent Claudication Major Product Offerings
7.3.4 Kowa Company Ltd. Intermittent Claudication Revenue in Global (2016-2021)
7.3.5 Kowa Company Ltd. Key News
7.4 LTT Bio-Pharma
7.4.1 LTT Bio-Pharma Corporate Summary
7.4.2 LTT Bio-Pharma Business Overview
7.4.3 LTT Bio-Pharma Intermittent Claudication Major Product Offerings
7.4.4 LTT Bio-Pharma Intermittent Claudication Revenue in Global (2016-2021)
7.4.5 LTT Bio-Pharma Key News
7.5 Pluristem Therapeutics Inc.
7.5.1 Pluristem Therapeutics Inc. Corporate Summary
7.5.2 Pluristem Therapeutics Inc. Business Overview
7.5.3 Pluristem Therapeutics Inc. Intermittent Claudication Major Product Offerings
7.5.4 Pluristem Therapeutics Inc. Intermittent Claudication Revenue in Global (2016-2021)
7.5.5 Pluristem Therapeutics Inc. Key News
7.6 Nuo Therapeutics, Inc.(Aldagen, Inc.)
7.6.1 Nuo Therapeutics, Inc.(Aldagen, Inc.) Corporate Summary
7.6.2 Nuo Therapeutics, Inc.(Aldagen, Inc.) Business Overview
7.6.3 Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Major Product Offerings
7.6.4 Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Revenue in Global (2016-2021)
7.6.5 Nuo Therapeutics, Inc.(Aldagen, Inc.) Key News
7.7 Genovate Biotechnology Co., Ltd.
7.7.1 Genovate Biotechnology Co., Ltd. Corporate Summary
7.7.2 Genovate Biotechnology Co., Ltd. Business Overview
7.7.3 Genovate Biotechnology Co., Ltd. Intermittent Claudication Major Product Offerings
7.4.4 Genovate Biotechnology Co., Ltd. Intermittent Claudication Revenue in Global (2016-2021)
7.7.5 Genovate Biotechnology Co., Ltd. Key News
7.8 Novartis AG
7.8.1 Novartis AG Corporate Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Intermittent Claudication Major Product Offerings
7.8.4 Novartis AG Intermittent Claudication Revenue in Global (2016-2021)
7.8.5 Novartis AG Key News
7.9 ID Pharma Co., Ltd
7.9.1 ID Pharma Co., Ltd Corporate Summary
7.9.2 ID Pharma Co., Ltd Business Overview
7.9.3 ID Pharma Co., Ltd Intermittent Claudication Major Product Offerings
7.9.4 ID Pharma Co., Ltd Intermittent Claudication Revenue in Global (2016-2021)
7.9.5 ID Pharma Co., Ltd Key News
7.10 Helixmith Co., Ltd.
7.10.1 Helixmith Co., Ltd. Corporate Summary
7.10.2 Helixmith Co., Ltd. Business Overview
7.10.3 Helixmith Co., Ltd. Intermittent Claudication Major Product Offerings
7.10.4 Helixmith Co., Ltd. Intermittent Claudication Revenue in Global (2016-2021)
7.10.5 Helixmith Co., Ltd. Key News
7.11 G. Pohl-Boskamp GmbH & Co. KG
7.11.1 G. Pohl-Boskamp GmbH & Co. KG Corporate Summary
7.11.2 G. Pohl-Boskamp GmbH & Co. KG Business Overview
7.11.3 G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Major Product Offerings
7.11.4 G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Revenue in Global (2016-2021)
7.11.5 G. Pohl-Boskamp GmbH & Co. KG Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Intermittent Claudication Market Opportunities & Trends in Global Market
Table 2. Intermittent Claudication Market Drivers in Global Market
Table 3. Intermittent Claudication Market Restraints in Global Market
Table 4. Key Players of Intermittent Claudication in Global Market
Table 5. Top Intermittent Claudication Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Intermittent Claudication Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Intermittent Claudication Revenue Share by Companies, 2016-2021
Table 8. Global Companies Intermittent Claudication Product Type
Table 9. List of Global Tier 1 Intermittent Claudication Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intermittent Claudication Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Intermittent Claudication Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Intermittent Claudication Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Intermittent Claudication Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Intermittent Claudication Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Intermittent Claudication Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Intermittent Claudication Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Intermittent Claudication Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Intermittent Claudication Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Intermittent Claudication Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Intermittent Claudication Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Intermittent Claudication Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Intermittent Claudication Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Intermittent Claudication Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Intermittent Claudication Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Intermittent Claudication Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Intermittent Claudication Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Intermittent Claudication Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Intermittent Claudication Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Intermittent Claudication Revenue, (US$, Mn), 2022-2027
Table 30. I'ROM GROUP(DNAVEC Corporation) Corporate Summary
Table 31. I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Product Offerings
Table 32. I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 33. Nuo Therapeutics Inc. Corporate Summary
Table 34. Nuo Therapeutics Inc. Intermittent Claudication Product Offerings
Table 35. Nuo Therapeutics Inc. Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 36. Kowa Company Ltd. Corporate Summary
Table 37. Kowa Company Ltd. Intermittent Claudication Product Offerings
Table 38. Kowa Company Ltd. Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 39. LTT Bio-Pharma Corporate Summary
Table 40. LTT Bio-Pharma Intermittent Claudication Product Offerings
Table 41. LTT Bio-Pharma Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 42. Pluristem Therapeutics Inc. Corporate Summary
Table 43. Pluristem Therapeutics Inc. Intermittent Claudication Product Offerings
Table 44. Pluristem Therapeutics Inc. Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 45. Nuo Therapeutics, Inc.(Aldagen, Inc.) Corporate Summary
Table 46. Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Product Offerings
Table 47. Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 48. Genovate Biotechnology Co., Ltd. Corporate Summary
Table 49. Genovate Biotechnology Co., Ltd. Intermittent Claudication Product Offerings
Table 50. Genovate Biotechnology Co., Ltd. Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 51. Novartis AG Corporate Summary
Table 52. Novartis AG Intermittent Claudication Product Offerings
Table 53. Novartis AG Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 54. ID Pharma Co., Ltd Corporate Summary
Table 55. ID Pharma Co., Ltd Intermittent Claudication Product Offerings
Table 56. ID Pharma Co., Ltd Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 57. Helixmith Co., Ltd. Corporate Summary
Table 58. Helixmith Co., Ltd. Intermittent Claudication Product Offerings
Table 59. Helixmith Co., Ltd. Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 60. G. Pohl-Boskamp GmbH & Co. KG Corporate Summary
Table 61. G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Product Offerings
Table 62. G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 1. Intermittent Claudication Market Opportunities & Trends in Global Market
Table 2. Intermittent Claudication Market Drivers in Global Market
Table 3. Intermittent Claudication Market Restraints in Global Market
Table 4. Key Players of Intermittent Claudication in Global Market
Table 5. Top Intermittent Claudication Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Intermittent Claudication Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Intermittent Claudication Revenue Share by Companies, 2016-2021
Table 8. Global Companies Intermittent Claudication Product Type
Table 9. List of Global Tier 1 Intermittent Claudication Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intermittent Claudication Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Intermittent Claudication Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Intermittent Claudication Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Intermittent Claudication Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Intermittent Claudication Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Intermittent Claudication Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Intermittent Claudication Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Intermittent Claudication Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Intermittent Claudication Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Intermittent Claudication Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Intermittent Claudication Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Intermittent Claudication Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Intermittent Claudication Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Intermittent Claudication Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Intermittent Claudication Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Intermittent Claudication Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Intermittent Claudication Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Intermittent Claudication Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Intermittent Claudication Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Intermittent Claudication Revenue, (US$, Mn), 2022-2027
Table 30. I'ROM GROUP(DNAVEC Corporation) Corporate Summary
Table 31. I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Product Offerings
Table 32. I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 33. Nuo Therapeutics Inc. Corporate Summary
Table 34. Nuo Therapeutics Inc. Intermittent Claudication Product Offerings
Table 35. Nuo Therapeutics Inc. Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 36. Kowa Company Ltd. Corporate Summary
Table 37. Kowa Company Ltd. Intermittent Claudication Product Offerings
Table 38. Kowa Company Ltd. Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 39. LTT Bio-Pharma Corporate Summary
Table 40. LTT Bio-Pharma Intermittent Claudication Product Offerings
Table 41. LTT Bio-Pharma Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 42. Pluristem Therapeutics Inc. Corporate Summary
Table 43. Pluristem Therapeutics Inc. Intermittent Claudication Product Offerings
Table 44. Pluristem Therapeutics Inc. Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 45. Nuo Therapeutics, Inc.(Aldagen, Inc.) Corporate Summary
Table 46. Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Product Offerings
Table 47. Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 48. Genovate Biotechnology Co., Ltd. Corporate Summary
Table 49. Genovate Biotechnology Co., Ltd. Intermittent Claudication Product Offerings
Table 50. Genovate Biotechnology Co., Ltd. Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 51. Novartis AG Corporate Summary
Table 52. Novartis AG Intermittent Claudication Product Offerings
Table 53. Novartis AG Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 54. ID Pharma Co., Ltd Corporate Summary
Table 55. ID Pharma Co., Ltd Intermittent Claudication Product Offerings
Table 56. ID Pharma Co., Ltd Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 57. Helixmith Co., Ltd. Corporate Summary
Table 58. Helixmith Co., Ltd. Intermittent Claudication Product Offerings
Table 59. Helixmith Co., Ltd. Intermittent Claudication Revenue (US$, Mn), (2016-2021)
Table 60. G. Pohl-Boskamp GmbH & Co. KG Corporate Summary
Table 61. G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Product Offerings
Table 62. G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Revenue (US$, Mn), (2016-2021)
LIST OF FIGURES
Figure 1. Intermittent Claudication Segment by Type
Figure 2. Intermittent Claudication Segment by Application
Figure 3. Global Intermittent Claudication Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Intermittent Claudication Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Intermittent Claudication Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Intermittent Claudication Revenue in 2020
Figure 8. By Type - Global Intermittent Claudication Revenue Market Share, 2016-2027
Figure 9. By Application - Global Intermittent Claudication Revenue Market Share, 2016-2027
Figure 10. By Region - Global Intermittent Claudication Revenue Market Share, 2016-2027
Figure 11. By Country - North America Intermittent Claudication Revenue Market Share, 2016-2027
Figure 12. US Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Intermittent Claudication Revenue Market Share, 2016-2027
Figure 16. Germany Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 17. France Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Intermittent Claudication Revenue Market Share, 2016-2027
Figure 24. China Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 28. India Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Intermittent Claudication Revenue Market Share, 2016-2027
Figure 30. Brazil Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Intermittent Claudication Revenue Market Share, 2016-2027
Figure 33. Turkey Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 37. I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Nuo Therapeutics Inc. Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Kowa Company Ltd. Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. LTT Bio-Pharma Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Pluristem Therapeutics Inc. Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Genovate Biotechnology Co., Ltd. Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Novartis AG Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. ID Pharma Co., Ltd Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Helixmith Co., Ltd. Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 1. Intermittent Claudication Segment by Type
Figure 2. Intermittent Claudication Segment by Application
Figure 3. Global Intermittent Claudication Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Intermittent Claudication Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Intermittent Claudication Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Intermittent Claudication Revenue in 2020
Figure 8. By Type - Global Intermittent Claudication Revenue Market Share, 2016-2027
Figure 9. By Application - Global Intermittent Claudication Revenue Market Share, 2016-2027
Figure 10. By Region - Global Intermittent Claudication Revenue Market Share, 2016-2027
Figure 11. By Country - North America Intermittent Claudication Revenue Market Share, 2016-2027
Figure 12. US Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Intermittent Claudication Revenue Market Share, 2016-2027
Figure 16. Germany Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 17. France Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Intermittent Claudication Revenue Market Share, 2016-2027
Figure 24. China Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 28. India Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Intermittent Claudication Revenue Market Share, 2016-2027
Figure 30. Brazil Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Intermittent Claudication Revenue Market Share, 2016-2027
Figure 33. Turkey Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Intermittent Claudication Revenue, (US$, Mn), 2016-2027
Figure 37. I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Nuo Therapeutics Inc. Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Kowa Company Ltd. Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. LTT Bio-Pharma Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Pluristem Therapeutics Inc. Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Genovate Biotechnology Co., Ltd. Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Novartis AG Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. ID Pharma Co., Ltd Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Helixmith Co., Ltd. Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
